BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2019 1:31:33 PM | Browse: 795 | Download: 1181
Publication Name World Journal of Gastroenterology
Manuscript ID 48381
Country/Territory Canada
Received
2019-04-19 02:35
Peer-Review Started
2019-04-19 02:37
To Make the First Decision
2019-06-10 08:02
Return for Revision
2019-06-11 01:15
Revised
2019-06-27 22:37
Second Decision
2019-07-01 09:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-07-03 01:08
Articles in Press
2019-07-03 01:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-08-14 07:12
Publish the Manuscript Online
2019-08-14 13:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape
Manuscript Source Invited Manuscript
All Author List Jean-Frédéric LeBlanc, Daniel Wiseman, Peter L Lakatos and Talat Bessissow
ORCID
Author(s) ORCID Number
Jean-Frédéric LeBlanc http://orcid.org/0000-0002-8477-6337
Daniel Wiseman http://orcid.org/0000-0001-6688-1670
Peter L Lakatos http://orcid.org/0000-0002-3948-6488
Talat Bessissow http://orcid.org/0000-0003-2610-1910
Funding Agency and Grant Number
Corresponding Author Talat Bessissow, FRCP (C), FRCPC, MD, MSc, Associate Professor, Doctor, Postdoctoral Fellow, Staff Physician, Division of Gastroenterology, McGill University Health Centre, 1650 Avenue Cedar C7-200, Montreal H3G1A4, QC, Canada. talat.bessissow@mcgill.ca
Key Words Inflammatory bowel disease; Elderly; Outcomes; Glucocorticoids; Biological therapy; Surgery
Core Tip Two types of inflammatory bowel disease (IBD) exist in the elderly (patients aged 60 or over): adult-onset vs elderly-onset. Disease phenotypes, outcomes and drug regimens may change based on the type of IBD. Recently, population-based trials have suggested increased corticosteroid use and decreased utilization of biologic agents in the elderly IBD population compared to their younger counterparts, likely owing to the perceived high rates of infections and malignancy from anti-tumor necrosis factor (TNF) agents. This article reviews the current available literature on the management of inflammatory bowel disease in the elderly patients, including anti-TNF agents, anti-integrin molecules, anti-interleukin 12/23 agents and IBD-related surgeries.
Publish Date 2019-08-14 13:31
Citation LeBlanc JF, Wiseman D, Lakatos PL, Bessissow T. Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape. World J Gastroenterol 2019; 25(30): 4158-4171
URL https://www.wjgnet.com/1007-9327/full/v25/i30/4158.htm
DOI https://dx.doi.org/10.3748/wjg.v25.i30.4158
Full Article (PDF) WJG-25-4158.pdf
Full Article (Word) WJG-25-4158.docx
Manuscript File 48381-Review.docx
Answering Reviewers 48381-Answering reviewers.pdf
Audio Core Tip 48381-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 48381-Conflict-of-interest statement.pdf
Copyright License Agreement 48381-Copyright license agreement.pdf
Peer-review Report 48381-Peer-review(s).pdf
Scientific Misconduct Check 48381-Google-MA RY-2.png
Scientific Misconduct Check 48381-Scientific misconduct check.pdf
Scientific Editor Work List 48381-Scientific editor work list.pdf